deltatrials
Completed PHASE3 INTERVENTIONAL 1-arm NCT03823521

Observational Study to Investigate the Effects of Training on the Administration of Cardioplexol™

A Multi-Center, Open Label, Single Group, Observational Study to Investigate the Effects of Training on the Administration of Cardioplexol™

Sponsor: Swiss Cardio Technologies AG

Conditions Coronary Artery Bypass Surgery Valve Surgery
Interventions Cardioplegia Solution
Updated 9 times since 2019 Last updated: Oct 20, 2021 Started: Nov 20, 2018 Primary completion: Oct 18, 2021 Completion: Oct 18, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Coronary Artery Bypass Surgery and Valve Surgery and is currently completed. Swiss Cardio Technologies AG leads this study, which shows 9 recorded versions since 2018 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

~Feb 2019 – ~Mar 2019 · 28 days · monthly snapshotRecruiting~Mar 2019 – ~Jul 2020 · 16 months · monthly snapshotRecruiting~Jul 2020 – ~Jan 2021 · 6 months · monthly snapshotRecruiting~Jan 2021 – ~Apr 2021 · 3 months · monthly snapshotRecruiting~Apr 2021 – ~Nov 2021 · 7 months · monthly snapshotRecruiting~Nov 2021 – ~Jul 2024 · 32 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 12 months · monthly snapshotCompleted

Change History

9 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE3

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  4. Nov 2021 — Jul 2024 [monthly]

    Completed PHASE3

    Status: Recruiting → Completed

  5. Apr 2021 — Nov 2021 [monthly]

    Recruiting PHASE3

▶ Show 4 earlier versions

  1. Jan 2021 — Apr 2021 [monthly]

    Recruiting PHASE3

  2. Jul 2020 — Jan 2021 [monthly]

    Recruiting PHASE3

  3. Mar 2019 — Jul 2020 [monthly]

    Recruiting PHASE3

  4. Feb 2019 — Mar 2019 [monthly]

    Recruiting PHASE3

    First recorded

Nov 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Swiss Cardio Technologies AG
Data source: Swiss Cardio Technologies AG

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations